Newsroom

SNS Web | New Delhi | September 23, 2020 1:25 pm

Natural born leader Abhita Batra merges her scientific expertise with superior management skills
In the biotechnology space, only a handful of companies manage to cut through the noise and successfully achieve their full potential in the midst of increasingly complex and volatile conditions.

View article

PUBLISHED: Sep 14, 2020 11:00:48 AM IST

Biotech CEO Abhita Batra champions groundbreaking magnetic drug delivery technology
Abhita Batra, a young and visionary scientist - turned Chief Executive Officer - is on a quest to successfully re-imagine patient experience.

View article

 AUGUST 6, 2020  BRYCE ROSS

This startup is working to improve children’s lives through technology

View article

By Barjunaid Penske, Author at Thrive Global
COMMUNITY//July 17, 2020

Entrepreneur Doesn’t Automatically Mean You’re a Born Leader – Abhita Batra
View article

GAITHERSBURG, Md. (February 27, 2020)
Abhita Batra, MS, MBA accepted into Forbes Business Council
View Press Release

July, 2020
Under CEO Abhita Batra, Otomagnetics is Poised to Become a Biotech Leader
View article

By IBTimes Staff Reporter, 02/17/20 AT 1:07 PM
Leading Companies That Are Disrupting Their industries
Otomagnetics is #8 in the article.
View article

GAITHERSBURG, MD (Feb. 1, 2020)
Non-invasive Magnetic Delivery Company Closes Series A of $2.33M
View Press Release

Oct. 8, 2018
Abhita Batra, Otomagnetics CEO, Aims to Change the Lives of Childhood Cancer
Survivors with Magnetic Drug Delivery Technology

View article

Sept. 25, 2018
Montgomery County Awards 12 Small Business Matching Grants

View article

April 11, 2018
Otomagnetics Adds Neela Chipalkatty to Board of Directors

View article

March 28, 2018 - Press Release
Otomagnetics Names Abhita Batra as CEO

View article

March 18, 2018

Angel MD Interview with Ben Shapiro from Otomagnetics

View interview

January 5, 2018

Otomagnetics is one of six startups awarded AngelMD’s Catalyst Fund during Alpha conference

View article

Oct. 12, 2017 - Rockville, Maryland

Otomagnetics Awarded a $2.3M Fast Track NIH/NCI SBIR Contract to Develop a Pediatric Cancer Drug Delivery System to Prevent Hearing Loss From Chemotherapy Regimens

View press release

July, 2017

AngelMD Announces Investment Into Innovative Magnetic Injection

Today, angelMD announced an investment into Otomagnetics, the developer of a magnetic injection delivery system. The investment was arranged through an angelMD member syndicate, and the group is led by Aditi Mandpe, MD and Orrin Ailloni-Charas, MD, MBA. This is angelMD’s first investment into Otomagnetics.

View article

Dec. 2016

TEDCO Invests $1.9 Million in 19 Startups to Support Innovation in Maryland

The Maryland Technology Development Corporation (TEDCO) announced today that 19 companies have received over $1.9 million in funding from the organization’s Seed Investment Fund in the last six months.

View article

Nov. 2016

Scientifically speaking...

I got phone calls from colleagues who were clinicians, saying, ‘‘We can’t get medicine through to the inner ear, can you help us?” The inner ear is protected by a ‘blood labyrinth’ barrier, in that it’s separated from the blood stream by cellular barriers. If you take medicines orally, very little of the drug gets into the cochlea.

View article